Medical Therapy. Efficacy or Lack of Efficacy

Rodolfo P. Moreno, Yanina Hernández, Patricia Garrido, Bethy Camargo Vargas, Alberto Hernández, Javier Faín, Cecilia Seligra, Patricia Topp, Alberto Maffey, Gustavo CardigniSanatorio de la Trinidad Palermo. Argintina Archives of Argentina PediatricsArch Argent Pediatr 2021; 119: e264-e268DOI: 10.5546/aap.2021.e264 AbstractDiffuse pulmonary lymphangiomatosis is a rare disease characterized by marked proliferation and dilation of lymphatic vessels in the lungs, […]

Satoshi Tamaoka, Asami Osada, Takane Kin, Takeshi Arimitsu, Mariko HidaKeio University School of Medicine.Japan ChestChest 2021; 159: e189-e191DOI: 10.1016/j.chest.2020.10.071 AbstractA trisomy 21 neonate presented with congenital chylous pleural effusion and ascites that was refractory to conventional pharmacotherapy. Midodrine, an oral alpha-1-adrenoreceptor agonist, achieved remission of chylous effusion without any adverse effects. To the best of our

Alvin Jia Hao Ngeow, Mei Yoke Chan, Oon Hoe Teoh, Sarat Kumar Sanamandra, Daisy Kwai Lin ChanSingapore General Hospital. KK Women’s and Children’s Hospital. Singapore British Medical Journals Case ReportsBMJ Case Rep 2021; 14: DOI: 10.1136/bcr-2020-240688 AbstractA Chinese male infant was born at 35 weeks weighing 2935 g to a mother with polyhydramnios and prenatal hydrops

I. Kankananarachchi, K. K. S. Priyankara, K. K. K. Lakman, K. Withanaarachchi, P. K. G. GunathilakaUniversity of Ruhuna. Teaching Hospital Karapitiya. Sri Lanka Case Reports in PediatricsCase Rep Pediatr 2021; DOI: 10.1155/2021/6634326 AbstractCongenital chylothorax (CC) is one of the most common causes of pleural effusions in neonates. Associated ipsilateral pulmonary aplasia in CC results in neonatal

Juma Obayashi, Shigeyuki Furuta, Yukitsugu Nakamura, Kunihide Tanaka, Hiroaki KitagawaSt. Marianna University School of Medicine. Japan Pediatrics InternationalPediatr Int 2022; 64: DOI: 10.1111/ped.14707 AbstractNo Abstract Available CategoryPulmonary Lymphatic DiseaseMedical Therapy. Efficacy or Lack of Efficacy Age Focus: Pediatric Pulmonary Vascular Disease Fresh or Filed Publication: Filed (PHiled). Greater than 1-2 years since publication Article Access Free

Hung-Lin Tai, Tze Yee Diane Mok, An-Shine Chao, Shih-Ming Chu, Reyin LienSaint Paul’s Hospital. Chang Gung Memorial Hospital. New Taipei Municipal TuCheng Hospital. Chang Gung Medical Center and Chang Gung University.Taiwan Frontiers in PediatricsFront Pediatr 2021; DOI: 10.3389/fped.2021.633051 AbstractBackground: Idiopathic congenital chylothorax is a rare but serious disease. Advancement in perinatal care and the renovated treatment modalities

A. Anvekar, G. Athalye-Jape, H. Panchal, S. Rao, R. KohanFiona Stanley Hospital. King Edward Memorial Hospital. Perth Children Hospital.Australia LymphologyLymphology 2021; 54: 204-213DOI Not Available AbstractNeonatal chylous effusions are rare entity with limited evidence-based management. We conducted a retrospective review of neonates admitted to King Edward Memorial and Princess Margaret/Perth Children’s Hospital over 20 years

Kaitlin Mitchell, Angela Weiner, Patricia Ramsay, Mitali SahniPediatrix Medical Group of Nevada and University of Nevada.United States PediatricsPediatrics 2021; 148: DOI: 10.1542/peds.2020-049699 AbstractChylothorax and chyloperitoneum are rare in infants and challenging to definitively diagnose by using current criteria extrapolated from the adult population. They can be of primary or secondary etiologies, including congenital lymphatic malformations and

Michaela Höck, Alexander Höller, Marlene Hammerl, Karina Wechselberger, Jakob Krösslhuber, Ursula Kiechl-Kohlendorfer, Sabine Scholl-Bürgi, Daniela KarallMedical University of Innsbruck. Austria Italian Journal of PediatricsItal J Pediatr 2021; 47: DOI: 10.1186/s13052-021-01125-1 AbstractBackground: Congenital chylothorax (CC) is a rare but potentially life-threatening condition in newborns. It is defined as an accumulation of chyle in the pleural cavity. The few